carboplatin
Carboplatin is a drug used to treat Lung Cancer, Ovarian Cancer, Breast Cancer, and other conditions. Carboplatin is being actively studied in 635 studies and prior, has been studied in 821.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| National Cancer Institute (NCI) | Washington University School of Medicine | Edward Neuwelt |
| M.D. Anderson Cancer Center | Roswell Park Cancer Institute | H.W.M. van Laarhoven |
| Eli Lilly and Company | University of Oklahoma Health Sciences Center | Ajay Gopal |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Non-small Cell Lung Cancer
- Atezolizumab(Tecentriq)
- +5 more
- Seoul, Gangnamgu, Korea, Republic ofSamsung Medical Center
2021-12-27
Dec 27, 2021A
S
Terminated
- Breast Neoplasm
- Decitabine
- Carboplatin
- Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
2022-03-28
Mar 28, 2022N
Active, not recruiting
- Adult Solid Neoplasm
- Carboplatin
- +4 more
- Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
2021-12-14
Dec 14, 2021U
Recruiting
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Carboplatin
- Pembrolizumab
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-10
Mar 10, 2022T
Active, not recruiting
- Breast Cancer
- Carboplatin
- Atezolizumab
- Amsterdam, Netherlands
- +3 more
2022-03-21
Mar 21, 2022U
Active, not recruiting
- Triple Negative Breast Cancer
- Carboplatin
- +3 more
- Chicago, IllinoisUniversity of Illinois
2022-01-28
Jan 28, 2022A
Completed
- Advanced Solid Tumors
- veliparib (ABT-888)
- +2 more
- (no location specified)
2021-07-29
Jul 29, 2021H
Active, not recruiting
- Breast Cancer
- Eribulin
- Carboplatin
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-12-13
Dec 13, 2021S
Active, not recruiting
- Testicular Neoplasms
- Seminoma
- Bleomycin Etoposide and Cisplatin
- Carboplatin
- Trondheim, NorwayInstitutt for kreftforskning og molekylær medisin, St Olavs Hosp
2021-11-05
Nov 5, 2021U
Recruiting
- Non-Small Cell Lung Cancer Metastatic
- Durvalumab
- +2 more
- Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
2022-03-01
Mar 1, 2022L
Recruiting
- Extensive-stage Small-cell Lung Cancer
- ZKAB001
- +3 more
- Shanghai, Shanghai, ChinaShanghai Chest Hospital
2021-09-08
Sep 8, 2021U
Completed
- Metastatic Medulloblastoma
- +2 more
- Carboplatin
- +2 more
- Aurora, ColoradoChildren's Hospital Colorado
2021-12-13
Dec 13, 2021N
Completed
- Ependymoma
- Anaplastic Ependymoma
- Carboplatin
- Bevacizumab
- Boston, Massachusetts
- +1 more
2021-11-29
Nov 29, 2021i
Completed
- Carcinoma, Non-Small-Cell Lung
- Nab-Paclitaxel
- Carboplatin
- Freiburg, Baden-Württemberg, GermanyiOMEDICO
2021-10-05
Oct 5, 2021A
Active, not recruiting
- Triple Negative Metastatic Breast Cancer
- +3 more
- KU-0059436 (AZD2281)(PARP inhibitor)
- +3 more
- Brussels, Belgium
- +2 more
2022-03-02
Mar 2, 2022A
Withdrawn
- Salivary Gland Carcinoma
- +3 more
- 9-ING-41
- Carboplatin
- Boston, MassachusettsDana-Farber Cancer Institute
2022-02-05
Feb 5, 2022G
Recruiting
- Salivary Gland Cancer
- +3 more
- 9-ING-41
- Carboplatin
- Boston, Massachusetts
- +1 more
2021-10-15
Oct 15, 2021U
Terminated
- Castration-Resistant Prostate Carcinoma
- +3 more
- Carboplatin
- +3 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-09-03
Sep 3, 2021N
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Carboplatin
- +2 more
- New Brunswick, New Jersey
- +2 more
2022-01-25
Jan 25, 2022U
Completed
- Castration Levels of Testosterone
- +5 more
- Carboplatin
- +2 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-01-24
Jan 24, 2022M
Recruiting
- Fallopian Tube Cancer
- +2 more
- Pembrolizumab
- +2 more
- Miami, FloridaUniversity of Miami
2021-12-24
Dec 24, 2021A
Completed
- Recurrent Fallopian Tube Carcinoma
- +2 more
- Carboplatin
- +2 more
- Bronx, New York
- +2 more
2021-10-18
Oct 18, 2021M
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- Refractory Malignant Solid Neoplasm
- Carboplatin
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-03-24
Mar 24, 2022G
Recruiting
- Solid Tumor, Adult
- Homologous Recombination Deficiency
- Niraparib
- Carboplatin
- Washington, District of Columbia
- +2 more
2021-08-31
Aug 31, 2021